Equity Analyzer
Cyera
AI-powered Data Security · Late-Stage Pre-IPO
Current Valuation
$9.0B
Series F · January 2026
Total Raised
$1.7B+
7 rounds · 2020–2026
Employees
~1,314
Tripled workforce in 12 months
Est. IPO Timeline
2027–2028
~24 months from now
Implied FMV/Share
$45
200M diluted shares
Revenue Growth
3.4×
Year-over-year (2025)

📈 Funding Timeline

Dec 2020
Seed Round
~$8M · Cyberstarts · Valuation ~$30M
Mar 2022
Series A · $56M
Valuation ~$230M · Accel, Sequoia
Jun 2023
Series B · $100M
Valuation $500M · Redpoint, Sequoia · Total: $160M
Apr 2024
Series C · $300M
Valuation $1.4B · Coatue, AT&T Ventures · Total: $460M
Nov 2024
Series D · $300M
Valuation $3.0B · Accel, Sapphire Ventures · Total: $760M
Jun 2025
Series E · $540M
Valuation $6.0B · Total: $1.3B
Jan 2026
Series F · $400M LATEST
Valuation $9.0B · Total: $1.7B+ · One of top-funded security startups 2025
Est. 2027–2028
IPO (Estimated) TARGET
~24 months · No formal S-1 filing yet · "Operating on pre-IPO timeline"
Context: Cyera's valuation tripled from $3B → $9B in 12 months (Nov 2024 → Jan 2026), driven by AI security demand. Revenue grew 3.4× YoY. 1/5 of Fortune 500 are customers. No formal IPO filing yet — SecurityWeek notes it's "operating on a pre-IPO timeline." Estimated IPO: 2027–2028.

Market Benchmarks

Equity ranges for Senior SE / IC-level roles at late-stage pre-IPO cybersecurity companies.

Holloway / Industry Benchmarks

Post-Series A Silicon Valley baseline — scaled down for late-stage reality

LevelPost-A %Late-Stage %
VP Engineering1.0–2.0%0.05–0.15%
Director0.4–1.25%0.02–0.06%
Lead / Staff Engineer0.5–1.0%0.003–0.008%
Senior SE (IC3)0.33–0.66%0.0013–0.0025%
Junior SE (IC2)0.2–0.33%0.0008–0.0015%

Late-stage = post-Series E/F. Apply ~200–300× reduction from post-A.

Comparable Companies

CompanyValuationSE LevelEst. Shares
Zscaler (Anchor)$1.9BJunior SE7,200
Wiz$12–20BSenior SE1,000–3,000 est.
CrowdStrike~$3B pre-IPOSE IC33,000–5,000 est.
Arctic Wolf~$4.3BSE2,000–4,000 est.
Illumio~$2.7BSE3,000–5,000 est.

Estimates based on valuation-adjusted ZS anchor. Actual data varies significantly.

Senior SE Equity Range — Your Company

Based on Cyera at $9.0B with 200M diluted shares. FMV: $45/share.

Shares Range for Senior SE (IC3)
LOW
MID
HIGH
OFFER
0
ScenarioShares% OwnershipValue @ CurrentValue @ 2× Exit
Market LOW2,6000.0013%$117K$234K
Market MEDIAN3,8000.0019%$171K$342K
Market HIGH5,0000.0025%$225K$450K
Your Offer2,0000.0010%$90K$180K
Note on DACH market: European late-stage candidates often receive 40–70% of US equity levels for equivalent roles. However, US-headquartered companies with EMEA offices (like Cyera) typically benchmark closer to US levels. The gap is narrowing in 2025–2026 as competition for technical talent intensifies.

📐 Ownership % Vergleich

Absoluter Ownership-% als Maßstab — unabhängig von Valuation-Niveau.

Position Shares Diluted Total Ownership % Wert bei Valuation
ZS Junior SE (Dez 2017) 7.200 (Vertrag) → 4.800 @IPO 118M ~0,004% $76K @IPO ($16/Share)
Cyera Angebot 2.000 300M est. 0,00067% ~$44K (409A)
Cyera LOW 4.500 300M est. 0,0015% ~$99K
Cyera TARGET 6.500 300M est. 0,0022% ~$143K
Cyera STRETCH 9.000 300M est. 0,003% ~$198K

Diluted share count Cyera: ~300M geschätzt (Basis: Series F Preis × Valuation). ZS: 118M diluted zum IPO (SEC S-1). Alle Werte vor Vesting und Steuern.

Anchor Analysis

Starting from the Zscaler reference point, adjusting for size, seniority, illiquidity, and region.

⚓ Reference Point: Zscaler (Dec 2017)

Company: Zscaler
Date: Dec 2017 (3mo pre-IPO)
Role: Junior SE
Valuation: $1.9B
Grant laut Vertrag: 7.200 Shares | nach 3:2 Reverse Split (Feb 2018): 4.800 Shares zum IPO | Wert @$16: $76.800
Ownership: ~0,004% (4.800 / 118M)
Grant-History: Vertragsstand Dezember 2017: 7.200 Shares. Zscaler führte im Februar 2018 — einen Monat vor dem IPO — einen 3:2 Reverse Split durch. Aus 7.200 Vertrags-Shares wurden 4.800 Shares zum IPO-Zeitpunkt.

IPO (März 2018): Preis $16/Share — die nachprüfbare Ankerzahl. Tag 1 eröffnete bei $27,50 (+72%) und schloss bei $33 (+106%). $16 ist der konservative Anker; $33 zeigt die realistische Marktaufnahme.

Lock-up: 180 Tage post-IPO → erste Verkaufsmöglichkeit September 2018, ZS handelte dann bei ca. $45–55/Share. Effektiver Liquiditätswert: ~$216K–$264K auf 4.800 Shares.

Ownership-Kontext: 4.800 / 118M diluted Shares = ~0,004%. $16 als konservativer Anker; $33 als Kontext für realistische Marktbewertung.

🧮 Calculation Steps

LOW
shares
TARGET
shares
STRETCH
shares
YOUR OFFER
shares
Gap to Target
— from offer

📊 Share Comparison Chart

Factor Summary

FactorLowTargetStretchRationale

Exit Scenarios

Projected value of your equity at various IPO/acquisition exit prices. IPO assumed in 24 months.

Your Offer
2,000 shares
$90,000 at current FMV
Target Ask
3,800 shares
$171,000 at current FMV
FMV/Share Now
$45
200M diluted shares
EUR/USD
1.08
Values shown in both currencies

Exit Value Table

Assumes constant diluted share count. For IPO, apply 10–15% additional dilution. 4-year vesting, no early liquidity.

Exit Valuation $/Share Offer (2K) LOW (2.7K) TARGET (3.8K) STRETCH (4.9K) $/Year (Target)

EUR Value (Target Scenario)

Exit Val.$/ShareUSD TotalEUR TotalEUR/Year (4yr vest)
Dilution note: At IPO, companies typically issue 10–15% new shares. This table uses current diluted shares as a baseline. For a more conservative estimate, multiply share price by 0.87 (assuming 13% IPO dilution). Cyera's last round was $400M at $9B (Jan 2026) — IPO likely 2027–2028.

Negotiation Playbook

Three structured counter-offer strategies based on anchor analysis and market data.

📌 Ausgangslage

"Mein ZS-Vertrag hatte 7.200 Shares bei $1,9 Mrd. Bewertung und 3 Monaten bis zur Liquidität. Heute bin ich Senior mit Leadership-Hintergrund, Cyera ist 5× größer, und die Liquidität ist 2–3 Jahre entfernt — plus Reverse Split wahrscheinlich. 2.000 Shares bildet das nicht ab."

📝 Talking Points

Anchor: Zscaler Reference
"Mein ZS-Vertrag hatte 7.200 Shares bei $1,9 Mrd. Bewertung und 3 Monaten bis zur Liquidität — nach dem Reverse Split 4.800 Shares (~0,004% Ownership). Adjusting for your $9B valuation, seniority uplift, and illiquidity premium, the market-equivalent is 3,800 shares."
Illiquidity Premium
"Zscaler was 3 months from IPO — near-liquid. Cyera is an estimated 24 months from IPO. Standard finance models apply a 25–30% illiquidity premium for a 2-year lock-up. That alone justifies ~500 additional shares."
Reverse Split — warum 2.000 Shares noch weniger sind als sie aussehen
"Reverse Splits vor dem IPO sind normal — Zscaler hat es einen Monat vor dem IPO gemacht. Aus 7.200 Vertrags-Shares wurden 4.800 am IPO-Tag. Wenn Cyera dasselbe macht, werden aus 2.000 Shares etwa 1.300. Das Angebot ist noch dünner als es auf dem Papier aussieht."
Market Benchmarks
"Comparable late-stage cybersecurity companies (Wiz at $12–20B, Arctic Wolf at $4.3B) grant Senior SEs 0.0013–0.0025% equity. At your diluted share count, that's 2,600–5,000 shares. The current offer of 2,000 is below the market LOW."
DACH & Cash Offset
"DACH-based compensation often runs 10–15% below US levels in cash. Equity is the mechanism to bridge that gap. A 10% DACH equity premium on a fair base adds another ~350 shares to the justified ask."

📊 What each option yields at exit

OptionShares@ $10B exit@ $15B exit@ $20B exitAnnual (4yr, $15B)
Strategy tip: Open with Stretch, expect Target. Frame the Signing Bonus as a separate conversation. If they can't move on shares, push for a 1-year cliff reduction or accelerated vesting on acquisition.

💸 Tender Offer — Kontext

Cyera Employee Tender Offer: 4. Februar 2026
Cyberstarts Employee Liquidity Fund + Evolution Equity Partners. Mitarbeiter konnten Anteile vor IPO verkaufen — ein frühes Liquiditätsfenster das bei Wettbewerbern selten ist.

Jährliches Programm geplant. Cyera hat signalisiert, dass Tender Offers ein wiederkehrendes Instrument bleiben — nicht ein einmaliges Event.

Einordnung: Das Tender-Programm ist eine positive Zusatzoption, keine Verhandlungsbasis. Es ändert nichts an der Berechtigung, mehr Equity zu verlangen — treat it as a separate benefit, not a replacement for fair initial grant terms.